Stem Cell Therapeutic and Research Reauthorization Act of 2026
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, Stem Cell Therapeutic and Research Reauthorization Act of 2026, changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Immigration, Science & Space.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H1CB4772074C34A37A2626D7FFFD37717: 1. Short title This Act may be cited as the Stem Cell Therapeutic and Research Reauthorization Act of 2026.
- Section H61AE7BFED251429AAE644448658F681F: 2. Reauthorization of the C.W. Bill Young Cell Transplantation Program Section 379B of the Public Health Service Act (42 U.S.C. 274m) is amended— by striking...
- Section HC4973ED8FDC44221ADB21ED28DE8D712: 3. Cord blood inventory Section 2(g) of the Stem Cell Therapeutic and Research Act of 2005 (42 U.S.C. 274k note) is amended by striking 2026 and inserting 2031.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, Stem Cell Therapeutic and Research Reauthorization Act of 2026, changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Immigration, Science & Space
Primary Purpose
This bill, Stem Cell Therapeutic and Research Reauthorization Act of 2026, changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
ReportedCommittee on Health, Education, Labor, and Pensions. Ordered to be …
Read twice and referred to the Committee on Health, Education, …
Introduced in Senate
Mr. Reed (for himself, Mr. Scott of South Carolina, Ms. …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "federal_implementing_agencies"
- → Federal agencies assigned duties by the bill
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology